Poison Control Program, 9585-9586 [2011-3751]

Download as PDF 9585 Federal Register / Vol. 76, No. 34 / Friday, February 18, 2011 / Notices January 31, 2011 (FR Doc. 2011–1997), on page 5389, regarding the Data System for Organ Procurement and Transplantation Network (42 CFR Part 121, OMB No. 0915–0184): Extension. The Burden Table is incorrect. Correction In the Federal Register issue of January 31, 2011 (FR Doc. 2011–1997), on page 5389, correct the Burden Table as follows: ESTIMATED ANNUAL REPORTING AND RECORDKEEPING BURDEN 121.3(b)(2) OPTN membership and application requirements ....... 121.3 Application for Non-Institutional Members .................... 121.3(b)(4) Appeal for OPTN membership ..................................... 121.6(c) (Reporting) Submitting criteria for organ acceptance ...................... 121.6(c) (Disclosure) Sending criteria to OPOs .............................................. 121.7(b)(4) Reasons for Refusal ..................................................... 121.7(f) Transplant to prevent organ wastage ........................... 121.9(b) Designated Transplant Program Requirements ........... 121.3 Personnel Change Application ..................................... 121.9(d) Appeal for designation .................................................. Dated: February 14, 2011. Reva Harris, Acting Director, Division of Policy and Information Coordination. BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Poison Control Program Health Resources and Services Administration, HHS. ACTION: Notice of Noncompetitive Replacement Awards to the Research Foundation of SUNY and the New York City Health & Hospitals Corporation. AGENCY: HRSA will transfer funds and duties from Kaleida Health and University of Rochester to the Research Foundation of SUNY d.b.a. the Upstate New York Poison Control Center. HRSA will also transfer funds and duties from Winthrop University to the New York City Health & Hospitals Corporation d.b.a. the New York City Poison Control Center. These transfers are necessary in order to maintain poison control services and education efforts throughout the State of New York. WReier-Aviles on DSKGBLS3C1PROD with NOTICES 13:57 Feb 17, 2011 Jkt 223001 Frm 00052 Total burden hours 120 15 1,800 20 1 20 10 200 2 1 2 3 6 900 1 900 0.5 450 900 1 900 0.5 450 900 38 34,200 0.5 17,100 260 1.5 390 0.5 195 10 1 10 5.0 50 324 1 324 10 3,240 2 1 2 6 12 954 ........................ 36,868 ........................ 23,503 Former Grantee of Record: Kaleida Health, University of Rochester; and Winthrop University are the three former grantees. Original Period of Grant Support is from: September 1, 2009 to August 31, 2014. Replacement awardees: The Research Foundation of SUNY and the New York City Health & Hospitals Corporation are the replacement awardees. Period of Replacement Awards: The period of support for the replacement awards is January 1, 2011, to August 31, 2011. Amount of Replacement Awards is as follows: ➢ Kaleida Health d.b.a. the Western New York Poison Center (H4BHS15474) will transfer $78,720 to the Research Foundation of SUNY d.b.a. the Upstate New York Poison Center (H4BHS15475); ➢ University of Rochester d.b.a. the Ruth A. Lawrence Poison and Drug Information Center (H4BHS15476) will transfer approximately $78,820 to the Research Foundation of SUNY d.b.a. the Upstate New York Poison Center (H4BHS15475); and ➢ Winthrop University d.b.a. the Long Island Regional Poison and Drug Information Center (H4BHS15478) will transfer $230,397 to the New York City Health & Hospitals Corporation d.b.a. PO 00000 Hours per response 3 SUPPLEMENTARY INFORMATION: [FR Doc. 2011–3755 Filed 2–17–11; 8:45 am] VerDate Mar<15>2010 Total responses 40 Total ....................................................................... SUMMARY: Responses per respondents Number of respondents Section and activity Fmt 4703 Sfmt 4703 the New York City Poison Control Center (H4BHS15477). Authority: Section 1273 of the PHS (42 U.S.C. 300d—73), as amended by Poison Center Support Enhancement and Awareness Act of 2008. CFDA Number: 93.253. Justification for the Exception to Competition The poison centers operated by the Research Foundation of SUNY and the New York City Health & Hospitals Corporation currently provide poison center services to the citizens of New York, 24 hours a day, 7 days a week. These services include telephone treatment advice and consultation about toxic exposures for both the public and health care professionals and toxico and public health surveillance. Educators at the centers provide public education about poison prevention and clinical toxicology training for many different healthcare professionals. The centers also offer programs to help clinicians better manage poisoning and overdose cases that end up in a healthcare facility. These centers have the capacity to provide poison control service to the areas formerly served by Kaleida Health, University of Rochester, and Winthrop University, ensuring access to critical poison emergency treatment and poison E:\FR\FM\18FEN1.SGM 18FEN1 9586 Federal Register / Vol. 76, No. 34 / Friday, February 18, 2011 / Notices prevention information statewide, and to fulfill the expectations of the original funded application. These replacement grants will also ensure that there is no delay or gap in poison center services. The State of New York has determined that the Research Foundation of SUNY and the New York City Health & Hospitals Corporation are the best qualified grantees for this award. On December 13, 2010, the State provided HRSA with a letter designating the two centers as the official poison centers of New York and assigning them specific service areas. FOR FURTHER INFORMATION CONTACT: Poison Control Program, Director, Elisa Gladstone via e-mail at EGladstone@hrsa.gov or via telephone at (301) 594–4394. Dated: February 14, 2011. Mary K. Wakefield, Administrator. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. WReier-Aviles on DSKGBLS3C1PROD with NOTICES [FR Doc. 2011–3778 Filed 2–17–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting BILLING CODE 4165–15–P Name of Committee: National Institute of Child Health and Human Development Initial Review Group; Function, Integration, and Rehabilitation Sciences Subcommittee. Date: March 22, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Anne Krey, PhD, Scientific Review Officer, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., 13:57 Feb 17, 2011 Dated: February 14, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2011–3751 Filed 2–17–11; 8:45 am] VerDate Mar<15>2010 Room 5b01, Bethesda, MD 20892. 301–435– 6908. ak41o@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Jkt 223001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Initial Review Group; Pediatrics Subcommittee. Date: March 17, 2011. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Rita Anand, PhD, Scientific Review Officer, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892. 301–496–1487. anandr@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 Dated: February 14, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–3776 Filed 2–17–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; R34/ T32 HIV and AIDS Applications. Date: March 9, 2011. Time: 9 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call.) Contact Person: David M. Armstrong, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center/ Room 6138/MSC 9608, 6001 Executive Boulevard, Bethesda, MD 20892–9608. 301– 443–3534.armstrda@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; HIV/ AIDS Behavioral Treatment Intervention. Date: March 9, 2011. Time: 4 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call.) Contact Person: David M. Armstrong, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center/ Room 6138/MSC 9608, 6001 Executive Boulevard, Bethesda, MD 20892–9608. 301– 443–3534. armstrda@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; NIH Summer Research Experience Programs. Date: March 14, 2011. E:\FR\FM\18FEN1.SGM 18FEN1

Agencies

[Federal Register Volume 76, Number 34 (Friday, February 18, 2011)]
[Notices]
[Pages 9585-9586]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-3751]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Poison Control Program

AGENCY: Health Resources and Services Administration, HHS.

ACTION: Notice of Noncompetitive Replacement Awards to the Research 
Foundation of SUNY and the New York City Health & Hospitals 
Corporation.

-----------------------------------------------------------------------

SUMMARY: HRSA will transfer funds and duties from Kaleida Health and 
University of Rochester to the Research Foundation of SUNY d.b.a. the 
Upstate New York Poison Control Center. HRSA will also transfer funds 
and duties from Winthrop University to the New York City Health & 
Hospitals Corporation d.b.a. the New York City Poison Control Center. 
These transfers are necessary in order to maintain poison control 
services and education efforts throughout the State of New York.

SUPPLEMENTARY INFORMATION: 
    Former Grantee of Record: Kaleida Health, University of Rochester; 
and Winthrop University are the three former grantees.
    Original Period of Grant Support is from: September 1, 2009 to 
August 31, 2014.
    Replacement awardees: The Research Foundation of SUNY and the New 
York City Health & Hospitals Corporation are the replacement awardees.
    Period of Replacement Awards: The period of support for the 
replacement awards is January 1, 2011, to August 31, 2011.
    Amount of Replacement Awards is as follows:
    [rtarr8] Kaleida Health d.b.a. the Western New York Poison Center 
(H4BHS15474) will transfer $78,720 to the Research Foundation of SUNY 
d.b.a. the Upstate New York Poison Center (H4BHS15475);
    [rtarr8] University of Rochester d.b.a. the Ruth A. Lawrence Poison 
and Drug Information Center (H4BHS15476) will transfer approximately 
$78,820 to the Research Foundation of SUNY d.b.a. the Upstate New York 
Poison Center (H4BHS15475); and
    [rtarr8] Winthrop University d.b.a. the Long Island Regional Poison 
and Drug Information Center (H4BHS15478) will transfer $230,397 to the 
New York City Health & Hospitals Corporation d.b.a. the New York City 
Poison Control Center (H4BHS15477).

    Authority:  Section 1273 of the PHS (42 U.S.C. 300d--73), as 
amended by Poison Center Support Enhancement and Awareness Act of 
2008.
    CFDA Number: 93.253.

Justification for the Exception to Competition

    The poison centers operated by the Research Foundation of SUNY and 
the New York City Health & Hospitals Corporation currently provide 
poison center services to the citizens of New York, 24 hours a day, 7 
days a week. These services include telephone treatment advice and 
consultation about toxic exposures for both the public and health care 
professionals and toxico and public health surveillance. Educators at 
the centers provide public education about poison prevention and 
clinical toxicology training for many different healthcare 
professionals. The centers also offer programs to help clinicians 
better manage poisoning and overdose cases that end up in a healthcare 
facility.
    These centers have the capacity to provide poison control service 
to the areas formerly served by Kaleida Health, University of 
Rochester, and Winthrop University, ensuring access to critical poison 
emergency treatment and poison

[[Page 9586]]

prevention information statewide, and to fulfill the expectations of 
the original funded application. These replacement grants will also 
ensure that there is no delay or gap in poison center services.
    The State of New York has determined that the Research Foundation 
of SUNY and the New York City Health & Hospitals Corporation are the 
best qualified grantees for this award. On December 13, 2010, the State 
provided HRSA with a letter designating the two centers as the official 
poison centers of New York and assigning them specific service areas.

FOR FURTHER INFORMATION CONTACT: Poison Control Program, Director, 
Elisa Gladstone via e-mail at EGladstone@hrsa.gov or via telephone at 
(301) 594-4394.

    Dated: February 14, 2011.
Mary K. Wakefield,
Administrator.
[FR Doc. 2011-3751 Filed 2-17-11; 8:45 am]
BILLING CODE 4165-15-P